Insider Trading Summary for Travere Therapeutics, Inc. (TVTX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-May-23 4:05 PM View:	17-May-23 Grant 0	Lyons Gary A Director		Travere Therapeutics, Inc. - TVTX	11% 40.0K to 44.5K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Meckler Jeffrey A Director		Travere Therapeutics, Inc. - TVTX	6% 70.0K to 74.5K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Coughlin Timothy P Director		Travere Therapeutics, Inc. - TVTX	12% 38.0K to 42.5K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:06 PM View:	17-May-23 Grant 0	Baynes Roy D. Director		Travere Therapeutics, Inc. - TVTX	23% 20.0K to 24.5K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:05 PM View:	01-Feb-24 Sale (Planned) ($22.95K)	Reed Elizabeth E SVP, GC & Corporate Secretary		Travere Therapeutics, Inc. - TVTX	33% 57.44K to 76.27K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:05 PM View:	01-Feb-24 Sale (Planned) ($22.95K)	Rote William E. Senior Vice President, R&D		Travere Therapeutics, Inc. - TVTX	34% 60.04K to 80.72K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Orwin John A Director		Travere Therapeutics, Inc. - TVTX	25% 17.88K to 22.38K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Squarer Ron Director		Travere Therapeutics, Inc. - TVTX	25% 17.88K to 22.38K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:06 PM View:	01-Feb-24 Sale (Planned) ($88.74K)	Dube Eric M Chief Executive Officer Director		Travere Therapeutics, Inc. - TVTX	48% 237.15K to 350.6K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:06 PM View:	17-May-23 Grant 0	Poole Sandra Director		Travere Therapeutics, Inc. - TVTX	36% 12.5K to 17.0K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:05 PM View:	01-Feb-24 Sale ($35.79K)	Heerma Peter Chief Commercial Officer		Travere Therapeutics, Inc. - TVTX	19% 83.35K to 99.5K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Bruhn Suzanne Louise Director		Travere Therapeutics, Inc. - TVTX	40% 11.25K to 15.75K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:05 PM View:	17-May-23 Grant 0	Brinkley Ruth W Director		Travere Therapeutics, Inc. - TVTX	55% 8.25K to 12.75K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:05 PM View:	01-Feb-24 Sale ($18.55K)	Inrig Jula Chief Medical Officer		Travere Therapeutics, Inc. - TVTX	54% 37.76K to 58.07K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:05 PM View:	01-Feb-24 Sale ($24.06K)	Calvin Sandra SVP, Chief Accounting Officer		Travere Therapeutics, Inc. - TVTX	22% 42.8K to 52.02K	0	0	--	--	Show Txns Hide Txns

12-Apr-24 4:05 PM View:	11-Apr-24 Sale ($0.36K)	Cline Christopher R. Chief Financial Officer		Travere Therapeutics, Inc. - TVTX	38% 51.49K to 70.85K	0	0	--	--	Show Txns Hide Txns

Travere Therapeutics, Inc. (TVTX)

Last Year

26-Apr-23 -- 25-Apr-24

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--